Regulation of SCI-induced pain by macrophages and exercise
巨噬细胞和运动对 SCI 引起的疼痛的调节
基本信息
- 批准号:10736378
- 负责人:
- 金额:$ 44.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-18 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAdjuvant TherapyAmericanAnalgesicsAttenuatedCellsChronicControl GroupsCyclic AMPDataDevelopmentDichloromethylene DiphosphonateDiseaseEncapsulatedEnzyme-Linked Immunosorbent AssayExerciseFlow CytometryFundingHarvestHealthcare SystemsHumanHydrophobicityImpairmentIn VitroIncidenceIndividualInfiltrationInflammationInflammatoryInjectionsInjuryInstitute of Medicine (U.S.)LiposomesMacrophageMacrophage ActivationMaintenanceMeasuresModelingMolecularNanodeliveryNeuroimmuneNeuronsNociceptorsPainPhenotypePhysiologicalPopulationPreventionProbabilityProcessRattusRegulationRehabilitation therapyReportingRoleRolipramSensorySerumSpinal GangliaSpinal cord injurySubgroupSystemTechnologyTestingTherapeuticWalkingaxonal sproutingchronic neuropathic painchronic paincostcytokinedisabilityexercise rehabilitationexosomeextracellular vesiclesimprovedin vivoinhibitorinjurednanopolymernanotherapeuticneuronal excitabilityneuropathologypain behaviorpain reductionpainful neuropathyphosphodiesterase IVpreventspinal cord injury paintransmission process
项目摘要
PROJECT SUMMARY
Spinal cord injury (SCI) impairs sensory transmission and leads to chronic, debilitating neuropathic
pain. Chronic pain afflicts over 100 million Americans and creates an enormous burden on US health care
systems, costing over half a trillion dollars annually according to a recent report from the Institute of Medicine.
While our understanding of the molecular basis underlying the development of chronic pain has improved, the
available therapeutics provide limited relief. While our lab and others have shown that early post-SCI rehab
can prevent pain development, early rehab in human SCI may not be possible due to the multisystem,
polytraumatic injuries individuals with SCI sustain. Thus, there is a critical need for an adjuvant therapy to aid
those individuals who are unable to participate in early rehab. Neuropathic pain is increasingly recognized as a
neuroimmune disorder. While macrophages are regarded as key regulators of chronic pain development, it is
unclear whether they are acting in an inflammatory or reparative manner. This R01 seeks to better understand
how or if the activation state of macrophages influences nociceptive neuron excitability and pain development
after SCI. We will utilize an established spinal cord injury model of neuropathic pain development and drive
macrophage activation state by post-injury rehab, intrathecal administration of exosomes derived from Raw
264.7 macrophages stimulated in vitro or a phosphodiesterase 4 inhibitor by a polymer nanodelivery system
that specifically targets macrophages. This proposal seeks to understand the role of macrophages that infiltrate
the dorsal root ganglia and persist there chronically after SCI both in the development and maintenance of
chronic neuropathic pain.
项目概要
脊髓损伤 (SCI) 会损害感觉传递并导致慢性、衰弱性神经病
疼痛。慢性疼痛困扰着超过一亿美国人,给美国医疗保健造成巨大负担
根据医学研究所最近的一份报告,该系统每年花费超过 5000 亿美元。
虽然我们对慢性疼痛发展的分子基础的了解有所提高,但
现有的治疗方法只能提供有限的缓解。虽然我们的实验室和其他实验室已经表明,脊髓损伤后早期康复
可以预防疼痛的发展,由于多系统,人类 SCI 的早期康复可能是不可能的,
患有 SCI 的人会遭受多发性损伤。因此,迫切需要辅助治疗来帮助
那些无法参加早期康复的人。神经性疼痛越来越被认为是一种
神经免疫紊乱。虽然巨噬细胞被认为是慢性疼痛发展的关键调节因子,但它
尚不清楚它们是否以炎症或修复方式起作用。此 R01 旨在更好地理解
巨噬细胞的激活状态如何或是否影响伤害感受神经元的兴奋性和疼痛的发展
SCI之后。我们将利用已建立的神经性疼痛发展和驱动的脊髓损伤模型
通过损伤后康复、鞘内注射源自 Raw 的外泌体来激活巨噬细胞
264.7 通过聚合物纳米递送系统体外刺激巨噬细胞或磷酸二酯酶 4 抑制剂
专门针对巨噬细胞。该提案旨在了解巨噬细胞渗透的作用
背根神经节并在 SCI 后长期存在于该处,以发展和维持
慢性神经性疼痛。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rolipram-loaded PgP nanoparticle reduces secondary injury and enhances motor function recovery in a rat moderate contusion SCI model.
负载咯利普兰的 PgP 纳米颗粒可减少大鼠中度挫伤 SCI 模型的继发性损伤并增强运动功能恢复。
- DOI:
- 发表时间:2023-09
- 期刊:
- 影响因子:0
- 作者:Gao, Jun;Khang, Min Kyung;Liao, Zhen;Webb, Ken;Detloff, Megan Ryan;Lee, Jeoung Soo
- 通讯作者:Lee, Jeoung Soo
Therapeutic targets and nanomaterial-based therapies for mitigation of secondary injury after spinal cord injury.
用于减轻脊髓损伤后继发性损伤的治疗靶点和基于纳米材料的疗法。
- DOI:10.2217/nnm-2021-0113
- 发表时间:2021-08-17
- 期刊:
- 影响因子:5.5
- 作者:Jun Gao;Minkyung Khang;Zhen Liao;M. Detloff;J. Lee
- 通讯作者:J. Lee
Modelling at-level allodynia after mid-thoracic contusion in the rat.
大鼠中胸挫伤后水平异常性疼痛的建模。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Blumenthal, Gary H;Nandakumar, Bharadwaj;Schnider, Ashley K;Detloff, Megan R;Ricard, Jerome;Bethea, John R;Moxon, Karen A
- 通讯作者:Moxon, Karen A
Plasticity in Cervical Motor Circuits following Spinal Cord Injury and Rehabilitation.
脊髓损伤和康复后颈椎运动回路的可塑性。
- DOI:
- 发表时间:2021-09-28
- 期刊:
- 影响因子:4.2
- 作者:Walker, John R;Detloff, Megan Ryan
- 通讯作者:Detloff, Megan Ryan
Exercise-Induced Changes to the Macrophage Response in the Dorsal Root Ganglia Prevent Neuropathic Pain after Spinal Cord Injury.
运动引起的背根神经节巨噬细胞反应的变化可预防脊髓损伤后的神经性疼痛。
- DOI:10.1089/neu.2018.5819
- 发表时间:2019-03-01
- 期刊:
- 影响因子:4.2
- 作者:Soha J. Chhaya;Daniel Quiros;Aless;ra Tamashiro;ra;J. Houlé;M. Detloff
- 通讯作者:M. Detloff
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MEGAN R DETLOFF其他文献
MEGAN R DETLOFF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MEGAN R DETLOFF', 18)}}的其他基金
Validation of Prenatal Rabbit Hypoxia Ischemia as a Model of Cerebral Palsy-induced Pain
产前兔缺氧缺血作为脑瘫引起的疼痛模型的验证
- 批准号:
10813313 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
Validation of Targeting Macrophage-Mediated Events in the DRG to Alleviate Chronic Spinal Cord Injury Pain
验证靶向 DRG 中巨噬细胞介导的事件以减轻慢性脊髓损伤疼痛
- 批准号:
9816362 - 财政年份:2017
- 资助金额:
$ 44.26万 - 项目类别:
Regulation of neuropathic pain by exercise: effects on nociceptor plasticity and inflammation
通过运动调节神经性疼痛:对伤害感受器可塑性和炎症的影响
- 批准号:
10226015 - 财政年份:2017
- 资助金额:
$ 44.26万 - 项目类别:
Regulation of neuropathic pain by exercise: effects on nociceptor plasticity and inflammation
通过运动调节神经性疼痛:对伤害感受器可塑性和炎症的影响
- 批准号:
9382617 - 财政年份:2017
- 资助金额:
$ 44.26万 - 项目类别:
Neuronal plasticity at remote sites causes neuropathic pain after SCI
远端部位的神经元可塑性导致 SCI 后神经性疼痛
- 批准号:
7274458 - 财政年份:2007
- 资助金额:
$ 44.26万 - 项目类别:
Neuronal plasticity at remote sites causes neuropathic pain after SCI
远端部位的神经元可塑性导致 SCI 后神经性疼痛
- 批准号:
7388160 - 财政年份:2007
- 资助金额:
$ 44.26万 - 项目类别:
相似国自然基金
基于二元重编程的归一化肿瘤疫苗在局部晚期三阴乳腺癌新辅助治疗中的作用与机制研究
- 批准号:32371451
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CTCFL调控IL-10抑制CD4+CTL旁观者激活促口腔鳞状细胞癌新辅助免疫治疗抵抗机制研究
- 批准号:82373325
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
构建多组学数据融合模型预测结直肠癌新辅助免疫治疗疗效的研究
- 批准号:82373431
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
食管癌新辅助治疗中靶向化疗耐药改善免疫治疗抵抗的机制发现和功能解析
- 批准号:82320108016
- 批准年份:2023
- 资助金额:210 万元
- 项目类别:国际(地区)合作与交流项目
机器学习辅助按需设计多酶活性纳米酶用于糖尿病足溃疡治疗研究
- 批准号:32371465
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Pathophysiological profiling of vocal fold hyperkeratosis
声带角化过度的病理生理学分析
- 批准号:
10365122 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别:
Pathophysiological profiling of vocal fold hyperkeratosis
声带角化过度的病理生理学分析
- 批准号:
10544046 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别:
Epigenetic regulators of subtype plasticity in bladder cancer
膀胱癌亚型可塑性的表观遗传调节因子
- 批准号:
10579267 - 财政年份:2021
- 资助金额:
$ 44.26万 - 项目类别:
Optimizing Thermal Ablation for Colon Cancer Liver Metastases: Rapid Tissue Analysis Allowing for Immediate Retreatment; Metabolic Imaging Biomarker Validation; and Predictive Genetic Signatures
优化结肠癌肝转移的热消融:快速组织分析可立即进行再治疗;
- 批准号:
10017172 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别:
Optimizing Thermal Ablation for Colon Cancer Liver Metastases: Rapid Tissue Analysis Allowing for Immediate Retreatment; Metabolic Imaging Biomarker Validation; and Predictive Genetic Signatures
优化结肠癌肝转移的热消融:快速组织分析可立即进行再治疗;
- 批准号:
10245245 - 财政年份:2019
- 资助金额:
$ 44.26万 - 项目类别: